335 related articles for article (PubMed ID: 17872918)
1. Comparative activity of pradofloxacin against anaerobic bacteria isolated from dogs and cats.
Silley P; Stephan B; Greife HA; Pridmore A
J Antimicrob Chemother; 2007 Nov; 60(5):999-1003. PubMed ID: 17872918
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of canine and feline bacterial pathogens to pradofloxacin and comparison with other fluoroquinolones approved for companion animals.
Schink AK; Kadlec K; Hauschild T; Brenner Michael G; Dörner JC; Ludwig C; Werckenthin C; Hehnen HR; Stephan B; Schwarz S
Vet Microbiol; 2013 Feb; 162(1):119-26. PubMed ID: 22939523
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal properties of pradofloxacin against veterinary pathogens.
Silley P; Stephan B; Greife HA; Pridmore A
Vet Microbiol; 2012 May; 157(1-2):106-11. PubMed ID: 22209121
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of rapidly growing mycobacteria and Nocardia isolates from cats and dogs to pradofloxacin.
Govendir M; Norris JM; Hansen T; Wigney DI; Muscatello G; Trott DJ; Malik R
Vet Microbiol; 2011 Dec; 153(3-4):240-5. PubMed ID: 21726965
[TBL] [Abstract][Full Text] [Related]
5. Comparative quantification of the in vitro activity of veterinary fluoroquinolones.
Grobbel M; Lübke-Becker A; Wieler LH; Froyman R; Friederichs S; Filios S
Vet Microbiol; 2007 Sep; 124(1-2):73-81. PubMed ID: 17498893
[TBL] [Abstract][Full Text] [Related]
6. Organisms isolated from dogs and cats with anaerobic infections and susceptibility to selected antimicrobial agents.
Jang SS; Breher JE; Dabaco LA; Hirsh DC
J Am Vet Med Assoc; 1997 Jun; 210(11):1610-4. PubMed ID: 9170087
[TBL] [Abstract][Full Text] [Related]
7. Pradofloxacin: a novel veterinary fluoroquinolone for treatment of bacterial infections in cats.
Sykes JE; Blondeau JM
Vet J; 2014 Aug; 201(2):207-14. PubMed ID: 24997792
[TBL] [Abstract][Full Text] [Related]
8. In vitro potency and efficacy favor later generation fluoroquinolones for treatment of canine and feline Escherichia coli uropathogens in the United States.
Liu X; Boothe DM; Jin Y; Thungrat K
World J Microbiol Biotechnol; 2013 Feb; 29(2):347-54. PubMed ID: 23136054
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics, pharmacodynamics and therapeutics of pradofloxacin in the dog and cat.
Lees P
J Vet Pharmacol Ther; 2013 Jun; 36(3):209-21. PubMed ID: 23406008
[TBL] [Abstract][Full Text] [Related]
10. Anaerobic infections in small animals.
Boothe DM
Probl Vet Med; 1990 Jun; 2(2):330-47. PubMed ID: 2134596
[TBL] [Abstract][Full Text] [Related]
11. Tuning of antibacterial activity of a cyclopropyl fluoroquinolone by variation of the substituent at position C-8.
Wetzstein HG; Hallenbach W
J Antimicrob Chemother; 2011 Dec; 66(12):2801-8. PubMed ID: 21948964
[TBL] [Abstract][Full Text] [Related]
12. A seven-year survey of susceptibility to marbofloxacin of pathogenic strains isolated from pets.
Meunier D; Acar JF; Martel JL; Kroemer S; Valle M
Int J Antimicrob Agents; 2004 Dec; 24(6):592-8. PubMed ID: 15555883
[TBL] [Abstract][Full Text] [Related]
13. Activity of garenoxacin against 536 unusual anaerobes including 128 recovered from acute pelvic infections.
Goldstein EJ; Citron DM; Tyrrell KL; Merriam CV
Diagn Microbiol Infect Dis; 2011 May; 70(1):131-6. PubMed ID: 21398076
[TBL] [Abstract][Full Text] [Related]
14. Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.
Peric M; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2004 Aug; 48(8):3188-92. PubMed ID: 15273148
[TBL] [Abstract][Full Text] [Related]
15. Comparison of pharmacodynamic and pharmacokinetic indices of efficacy for 5 fluoroquinolones toward pathogens of dogs and cats.
Boothe DM; Boeckh A; Simpson RB; Dubose K
J Vet Intern Med; 2006; 20(6):1297-306. PubMed ID: 17186841
[TBL] [Abstract][Full Text] [Related]
16. Resistance of canine methicillin-resistant Staphylococcus pseudintermedius strains to pradofloxacin.
Kizerwetter-Świda M; Chrobak-Chmiel D; Rzewuska M; Binek M
J Vet Diagn Invest; 2016 Sep; 28(5):514-8. PubMed ID: 27449131
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamics of ibafloxacin in micro-organisms isolated from cats.
Coulet M; Cox P; Lohuis J
J Vet Pharmacol Ther; 2005 Feb; 28(1):29-36. PubMed ID: 15720512
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility of canine and feline Escherichia coli and canine Staphylococcus intermedius isolates to fluoroquinolones.
Gottlieb S; Wigney DI; Martin PA; Norris JM; Malik R; Govendir M
Aust Vet J; 2008 Apr; 86(4):147-52. PubMed ID: 18363989
[TBL] [Abstract][Full Text] [Related]
19. Orbital abscess bacterial isolates and in vitro antimicrobial susceptibility patterns in dogs and cats.
Wang AL; Ledbetter EC; Kern TJ
Vet Ophthalmol; 2009; 12(2):91-6. PubMed ID: 19261163
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of subgingival bacterial flora in dogs with gingivitis.
Harvey CE; Thornsberry C; Miller BR; Shofer FS
J Vet Dent; 1995 Dec; 12(4):151-5. PubMed ID: 9693643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
